Legend Biotech Announces Participation in Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
SOMERSET, N.J.--(BUSINESS WIRE)--
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences:
Event: BMO Biopharma Spotlight Series: Oncology Day (Virtual)
Fireside Chat Date & Time: Wednesday, November 9, 2022 at 1:30pm ET Presenter: Ying Huang, Ph.D., CEO
Event: Cowen 6th Annual IO Next Summit (Virtual)
Fireside Chat Date & Time: Friday, November 11, 2022 at 1:10pm ET Presenter: Ying Huang, Ph.D., CEO
Event:JP Morgan Equity Opportunities Forum Location:Miami, Florida Date: Monday, November 14, 2022
Event:Jefferies London Healthcare Conference Location:London Fireside Chat Date & Time: Thursday, November 17, 2022 at 2:40pm GMT Presenter:Ying Huang, Ph.D., CEO
Event: Piper 34th Annual Healthcare Conference
Location:New York, New York Fireside Chat Date & Time: Tuesday, November 29, 2022 at 3:00pm ET Presenter:Ying Huang, Ph.D., CEO
Event:Evercore ISI 5th Annual HealthCONx Conference (Virtual)
Fireside Chat Date & Time: Wednesday, November 30, 2022 at 9:40am ET Presenter:Ying Huang, Ph.D., CEO
About Legend Biotech
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.
